Antifungal activity of melanin in clinical isolates of Candida spp.

被引:4
|
作者
Fuentes, Marso [1 ]
Hernandez, Romane [1 ]
Gordillo, Diego [1 ]
Amaro, Jose [1 ]
Falconer, Mary A. [1 ]
Alburquenque, Claudio [2 ]
Tapia, Cecilia V. [1 ]
机构
[1] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Microbiol & Micol, Santiago, Chile
[2] Univ Mayor, Escuela Tecnol, Santiago, Chile
来源
REVISTA CHILENA DE INFECTOLOGIA | 2014年 / 31卷 / 01期
关键词
Melanin; melanocyte; antifungal activity; Candida spp; MELANOCYTES; VIRULENCE; BIOLOGY; CELLS; SKIN;
D O I
10.4067/S0716-10182014000100004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Melanocytes are cells located in epidermis and mucous membranes that synthesize melanin and cytokines. It is known that melanin has antimicrobial activity and that melanocytes are melanized in presence of microbial molecules. Objective: To study the antifungal activity of melanin on Candida spp. Methodology: The minimum inhibitory concentration (MIC) to melanin was determined in 4 Candida ATCC strains (C. albicans SC5314, C. parapsilosis 22019, C. glabrata 2001, C. krusei 6258) and 56 clinical isolates of Candida spp. (33 C. albicans, 12 C. glabrata, 3 C. famata, 3 C. krusei, 3 C. parapsilosis, 2 C. tropicalis) using a broth microdilution method. In addition, the antifungal activity of melanocytes and mice melanoma cells was tested against C. albicans. Results: Melanin inhibited the tested isolates, including the susceptible dose-dependent and fluconazole-resistant strains; MIC range and MIC(50)were 0.09-50 mu g/mL and 6.25 mu g/mL, respectively. Pigmented cells lysates inhibited C. albicans. Conclusions: Melanin is able to inhibit clinical isolates of Candida spp. Melanization could be an important protective mechanism of melanocytes.
引用
收藏
页码:28 / 33
页数:6
相关论文
共 50 条
  • [31] Primary resistance to flucytosine among clinical isolates of Candida spp.
    Barchiesi, F
    Arzeni, D
    Caselli, F
    Scalise, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) : 408 - 409
  • [32] Antifungal Activity of Olive Oil and Ozonated Olive Oil Against Candida Spp. and Saprochaete Spp.
    Varol, Kemal
    Koc, Ayse Nedret
    Atalay, Mustafa Altay
    Keles, Ihsan
    OZONE-SCIENCE & ENGINEERING, 2017, 39 (06) : 462 - 470
  • [33] Identification and susceptibility of clinical isolates of Candida spp. to killer toxins
    Robledo-Leal, E.
    Rivera-Morales, L. G.
    Sangorrin, M. P.
    Gonzalez, G. M.
    Ramos-Alfano, G.
    Adame-Rodriguez, J. M.
    Alcocer-Gonzalez, J. M.
    Arechiga-Carvajal, E. T.
    Rodriguez-Padilla, C.
    BRAZILIAN JOURNAL OF BIOLOGY, 2018, 78 (04) : 742 - 749
  • [34] Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates
    Roscetto, Emanuela
    Contursi, Patrizia
    Vollaro, Adriana
    Fusco, Salvatore
    Notomista, Eugenio
    Catania, Maria Rosaria
    SCIENTIFIC REPORTS, 2018, 8
  • [35] In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp.
    Barchiesi, F.
    Giacometti, A.
    Cirioni, O.
    Arzeni, D.
    Kamysz, W.
    Silvestri, C.
    Licci, A.
    Marigliano, A.
    Della Vittoria, A.
    Nadolski, P.
    Lukasiak, J.
    Scalise, G.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (05) : 514 - 518
  • [36] Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates
    Emanuela Roscetto
    Patrizia Contursi
    Adriana Vollaro
    Salvatore Fusco
    Eugenio Notomista
    Maria Rosaria Catania
    Scientific Reports, 8
  • [37] Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II: Antifungal Activity against Reference Strains and Clinical Isolates of Candida spp.
    Aguirre-Guataqui, Katherine
    Marquez-Torres, Mateo
    Manuel Pineda-Castaneda, Hector
    Vargas-Casanova, Yerly
    Ceballos-Garzon, Andres
    Jenny Rivera-Monroy, Zuly
    Eduardo Garcia-Castaneda, Javier
    Marcela Parra-Giraldo, Claudia
    ANTIBIOTICS-BASEL, 2022, 11 (11):
  • [38] In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis
    Pinto, Patricia M.
    Botelho Weikert-Oliveira, Rita de Cassia
    Lyon, Juliana Pereira
    Cury, Veronica F.
    Arantes, Rodrigo R.
    Koga-Ito, Cristiane Y.
    Resende, Maria A.
    MICROBIOLOGICAL RESEARCH, 2008, 163 (05) : 579 - 585
  • [39] Evaluation of Biofilm Production and Antifungal Susceptibility to Fluconazole in Clinical Isolates of Candida spp. in Both Planktonic and Biofilm Form
    Marzucco, Anna
    Gatti, Giulia
    Montanari, Maria Sofia
    Fantini, Michela
    Colosimo, Claudia
    Tamburini, Maria Vittoria
    Arfilli, Valentina
    Morotti, Manuela
    Schiavone, Pasqualina
    Congestri, Francesco
    Manera, Martina
    Denicolo, Agnese
    Brandolini, Martina
    Taddei, Francesca
    Grumiro, Laura
    Zannoli, Silvia
    Dirani, Giorgio
    De Pascali, Alessandra Mistral
    Sambri, Vittorio
    Cricca, Monica
    MICROORGANISMS, 2024, 12 (01)
  • [40] Antifungal Activity of Turkish Honey against Candida spp. and Trichosporon spp: an in vitro evaluation
    Koc, Ayse Nedret
    Silici, Sibel
    Ercal, Baris Derya
    Kasap, Filiz
    Hormet-Oz, Hatice Tuna
    Mavus-Buldu, Hikmet
    MEDICAL MYCOLOGY, 2009, 47 (07) : 707 - 712